About AVT
Browse Articles
Authors
Customer Services

Browse Articles

Additional files for manuscripts published before Volume 14 Issue 6 can be found via the abstract link.

Articles published electronically ahead of print and our archive from Volume 4 Issue 1 to Volume 22 Issue 1 can be found below. Articles published earlier will be made available as soon as possible. If you require an article that cannot be found below, please contact the Editorial Office.

Currently showing:   
Displaying 2087 results:

Correction

Correction: HBV genotypes and drug resistance mutations in antiretroviral treatment-naive and treatment-experienced HBV–HIV-coinfected patients

Timothy NA Archampong, Ceejay L Boyce, Margaret Lartey, Kwamena W Sagoe, Adjoa Obo-Akwa, Ernest Kenu, Jason T Blackard, Awewura Kwara

Antiviral Therapy 2017; 22:91


Case report

Acute leg ischaemia in an HIV-infected patient receiving antiretroviral treatment

Jordi Navarro, Adrian Curran, Joaquin Burgos, Ariadna Torrella, Inma Ocaña, Vicenç Falcó, Manuel Crespo, Esteban Ribera

Antiviral Therapy 2017; 22:89-90


Short communication

Effect of antiviral therapy for HCV on lipid levels

Stefan Mauss, Florian Berger, Malte H Wehmeyer, Patrick Ingiliz, Dietrich Hueppe, Thomas Lutz, Karl G Simon, Knud Schewe, Juergen K Rockstroh, Axel Baumgarten, Stefan Christensen

Antiviral Therapy 2017; 22:81-88


Short communication

Outcomes of acutely HIV-1-infected individuals following rapid antiretroviral therapy initiation

Nicolò Girometti, Nneka Nwokolo, Alan McOwan, Gary Whitlock

Antiviral Therapy 2017; 22:77-80


Short communication

Treatment of HIV infection with a raltegravir-based regimen increases LDL levels, but improves HDL cholesterol efflux capacity

Nicholas T Funderburg, Dihua Xu, Martin P Playford, Aditya A Joshi, Adriana Andrade, Daniel R Kuritzkes, Michael M Lederman, Nehal N Mehta

Antiviral Therapy 2017; 22:71-75


Original article

Comparison of the Abbott RealTime HCV and Roche COBAS Ampliprep/COBAS TaqMan HCV assays for the monitoring of sofosbuvir-based therapy

Eiichi Ogawa, Norihiro Furusyo, Masayuki Murata, Motohiro Shimizu, Kazuhiro Toyoda, Taeko Hotta, Takeshi Uchiumi, Jun Hayashi

Antiviral Therapy 2017; 22:61-70


Original article

Factors associated with HBV virological breakthrough

Suzanne Sheppard-Law, Iryna Zablotska-Manos, Melissa Kermeen, Susan Holdaway, Alice Lee, Amany Zekry, Gregory J Dore, Jacob George, Lisa Maher

Antiviral Therapy 2017; 22:53-60


Original article

Small surface antigen variants of HBV associated with responses to telbivudine treatment in chronic hepatitis B patients

Hui Dong, Bin Zhou, Hui Kang, Weirong Jin, Yongqiang Zhu, Yan Shen, Jian Sun, Shengyue Wang, Guoping Zhao, Jinlin Hou, Yungang He

Antiviral Therapy 2017; 22:43-51


Original article

Renal outcomes after up to 8 years of tenofovir exposure in HIV–HBV-coinfected patients

Anders Boyd, Patrick Miailhes, Caroline Lascoux-Combe, Hayette Rougier, Pierre-Marie Girard, Emmanuelle Plaisier, Karine Lacombe

Antiviral Therapy 2017; 22:31-42


Original article

Combined effect of sex and age in response to antiretroviral therapy in HIV-infected patients

Jose Ramón Blanco, Inma Jarrin, Maria Jesús Pérez-Elías, Félix Gutiérrez, José Hernández-Quero, Joaquín Portilla, David Dalmau, Santiago Moreno, Victoria Hernando, CoRIS

Antiviral Therapy 2017; 22:21-29


Page:
Copyright © Nucleus Global 2017. Part of Nucleus Global.
Design and Technology by Nucleus Global
Company registration No. 321 0712 (England & Wales). Registered Office address: Admiral House 76-78 Old Street, London EC1V 9AZ.